Merck & Co., Inc. (NEO:MRK)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of CAD 301.31 billion. The enterprise value is 333.98 billion.

Market Cap	301.31B
Enterprise Value	333.98B

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	80.42%
Float	2.48B

Valuation Ratios

The trailing PE ratio is 11.36 and the forward PE ratio is 9.41.

PE Ratio	11.36
Forward PE	9.41
PS Ratio	3.37
PB Ratio	4.17
P/TBV Ratio	14.47
P/FCF Ratio	16.58
P/OCF Ratio	12.68
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.02, with an EV/FCF ratio of 18.37.

EV / Earnings	12.60
EV / Sales	3.70
EV / EBITDA	8.02
EV / EBIT	9.52
EV / FCF	18.37

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.80.

Current Ratio	1.66
Quick Ratio	1.09
Debt / Equity	0.80
Debt / EBITDA	1.40
Debt / FCF	3.17
Interest Coverage	19.57

Financial Efficiency

Return on equity (ROE) is 39.49% and return on invested capital (ROIC) is 17.71%.

Return on Equity (ROE)	39.49%
Return on Assets (ROA)	12.61%
Return on Invested Capital (ROIC)	17.71%
Return on Capital Employed (ROCE)	24.71%
Revenue Per Employee	1.21M
Profits Per Employee	358,274
Employee Count	75,000
Asset Turnover	0.52
Inventory Turnover	2.24

Taxes

In the past 12 months, Merck & Co. has paid 3.86 billion in taxes.

Income Tax	3.86B
Effective Tax Rate	12.71%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	19.21
200-Day Moving Average	n/a
Relative Strength Index (RSI)	52.54
Average Volume (20 Days)	18,164

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.27

Income Statement

In the last 12 months, Merck & Co. had revenue of CAD 89.47 billion and earned 26.51 billion in profits. Earnings per share was 10.52.

Revenue	89.47B
Gross Profit	69.66B
Operating Income	34.73B
Pretax Income	30.39B
Net Income	26.51B
EBITDA	40.77B
EBIT	34.73B
Earnings Per Share (EPS)	10.52

Balance Sheet

The company has 25.37 billion in cash and 57.63 billion in debt, giving a net cash position of -32.26 billion.

Cash & Cash Equivalents	25.37B
Total Debt	57.63B
Net Cash	-32.26B
Net Cash Per Share	n/a
Equity (Book Value)	72.30B
Book Value Per Share	29.04
Working Capital	26.37B

Cash Flow

In the last 12 months, operating cash flow was 23.77 billion and capital expenditures -5.59 billion, giving a free cash flow of 18.18 billion.

Operating Cash Flow	23.77B
Capital Expenditures	-5.59B
Free Cash Flow	18.18B
FCF Per Share	n/a

Margins

Gross margin is 77.85%, with operating and profit margins of 38.82% and 29.63%.

Gross Margin	77.85%
Operating Margin	38.82%
Pretax Margin	33.96%
Profit Margin	29.63%
EBITDA Margin	45.56%
EBIT Margin	38.82%
FCF Margin	20.31%

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	42.60%
Buyback Yield	0.91%
Shareholder Yield	0.91%
Earnings Yield	8.80%
FCF Yield	6.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.83 and a Piotroski F-Score of 5.

Altman Z-Score	3.83
Piotroski F-Score	5